Access to medicines in the Brazilian Unified Health System's primary health care: assessment of a public policy

被引:4
作者
Barbosa, Mariana M. [1 ]
Moreira, Thais A. [2 ]
Nascimento, Renata C. R. M. [3 ]
Nascimento, Mariana M. G. [1 ]
Acurcio, Francisco A. [1 ]
Godman, Brian [4 ,5 ,6 ,7 ]
Guerra, Augusto A. [1 ]
Alvares-Teodoro, Juliana [1 ]
机构
[1] Fed Univ Minas Gerais UFMG, Postgrad Program Med & Pharmaceut Serv, Sch Pharm, Belo Horizonte, MG, Brazil
[2] Fed Univ Minas Gerais UFMG, Postgrad Program Publ Hlth, Sch Med, Belo Horizonte, MG, Brazil
[3] Univ Fed Ouro Preto, Sch Pharm, Dept Pharm, Ouro Preto, Brazil
[4] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland
[5] Univ Liverpool, Ctr Hlth Econ, Management Sch, Liverpool, Merseyside, England
[6] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Clin Pharmacol, SE-14186 Stockholm, Sweden
[7] Sefako Makgatho Hlth Sci Univ, Sch Pharm, Pretoria, South Africa
关键词
access to medicines; health services accessibility; infrastructure; pharmaceutical services; Rede Farmá cia de Minas; PROTON PUMP INHIBITORS; PRESCRIBING EFFICIENCY; SATISFACTION; SERVICES; ENHANCE; QUALITY; EUROPE;
D O I
10.2217/cer-2021-0026
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In 2008, the Programa Rede Farmacia de Minas (RFM, literally translated: 'Minas Gerais Pharmacy Network' program) was created as a strategy to expand access to medicines. Aim: Measure access to medicines in public pharmacies through comparison between municipalities that joined or not the RFM. Materials & methods: Cross-sectional, evaluative study, gathering information from a representative sample of the municipalities in Minas Gerais between July 2014 and May 2015. The Poisson regression results were obtained by calculating the prevalence ratios. Results: Adequate access to medicines in Minas Gerais was 69.9%, being 75.8% in municipalities with and 69.2% without the RFM. The municipalities with the RFM showed statistically higher percentages in the Availability, Adequacy/Accommodation, and Acceptability dimensions. Conclusion: RFM appears an efficient strategy for promoting access to medicines.
引用
收藏
页码:869 / 879
页数:11
相关论文
共 26 条
[1]  
Alvares J, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051007139, 10.11606/s1518-8787.2017051007139]
[2]  
[Anonymous], 2010, CENS DEM 2010
[3]   Infrastructure evaluation of Pharmaceutical Services in the National Health System of Minas Gerais [J].
Barbosa, Mariana Michel ;
Garcia, Marina Morgado ;
Rezende Macedo do Nascimento, Renata Cristina ;
Reis, Edna Afonso ;
Guerra Junior, Augusto Afonso ;
Acurcio, Francisco De Assis ;
Alvares, Juliana .
CIENCIA & SAUDE COLETIVA, 2017, 22 (08) :2475-2486
[4]   Procurement of generic medicines in a medium size municipality [J].
Bevilacqua, Gabriela ;
Farias, Mareni Rocha ;
Blatt, Carine Raquel .
REVISTA DE SAUDE PUBLICA, 2011, 45 (03) :583-589
[5]   Sources of medicines for hypertension and diabetes in Brazil: telephone survey results from Brazilian state capitals and the Federal District, 2011 [J].
Costa, Karen Sarmento ;
Bergamo Francisco, Priscila Maria S. ;
Malta, Debora Carvalho ;
de Azevedo Barros, Marilisa Berti .
CADERNOS DE SAUDE PUBLICA, 2016, 32 (02)
[6]   Medication use patterns among elderly people in urban area in Northeastern Brazil [J].
Filho, JMC ;
Marcopito, LF ;
Castelo, A .
REVISTA DE SAUDE PUBLICA, 2004, 38 (04) :557-564
[7]   Indicator of access to medicines in relation to the multiple dimensions of access [J].
Garcia, Marina M. ;
Barbosa, Mariana M. ;
Silva, Rondineli M. ;
Reis, Edna A. ;
Alvares, Juliana ;
Acurcio, Francisco de Assis ;
Godman, Brian ;
Guerra Junior, Augusto A. .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (12) :1027-1039
[8]   Pricing of oral generic cancer medicines in 25 European countries; findings and implications [J].
Godman, Brian ;
Hill, Andrew ;
Simoens, Professor Steven ;
Kurdi, Amanj ;
Gulbinovic, Jolanta ;
Martin, Antony P. ;
Timoney, Angela ;
Gotham, Dzintars ;
Wale, Janet ;
Bochenek, Tomasz ;
Rothe, Celia C. ;
Hoxha, Iris ;
Malaj, Admir ;
Hierlaender, Christian ;
Sauermann, Robert ;
Hamelinck, Wouter ;
Mitkova, Zornitsa ;
Petrova, Guenka ;
Laius, Ott ;
Sermet, Catherine ;
Langer, Irene ;
Selke, Gisbert W. ;
Yfantopoulos, John ;
Joppi, Roberta ;
Jakupi, Arianit ;
Poplavska, Elita ;
Greiciute-Kuprijanov, Ieva ;
Bonanno, Patricia Vella ;
Piepenbrink, J. F. ;
de Valk, Vincent ;
Hagen, Carolin ;
Ringerud, Anne Marthe ;
Plisko, Robert ;
Wladysiuk, Magdalene ;
Markovic-Pekovic, Vanda ;
Grubisa, Natasa ;
Ponorac, Tatjana ;
Mardare, Ileana ;
Novakovic, Tanja ;
Parker, Mark ;
Furst, Jurij ;
Tomek, Dominik ;
Cortadellas, Merce Obach ;
Zara, Corinne ;
Juhasz-Haverinen, Maria ;
Skiold, Peter ;
McTaggart, Stuart ;
Haycox, Alan .
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2019, 8 (02) :49-70
[9]   Ongoing activities to influence the prescribing of proton pump inhibitors within the Scottish National Health Service: their effect and implications [J].
Godman, Brian ;
Baker, Amanj ;
McCabe, Holly ;
MacBride-Stewart, Sean ;
Leporowski, Axel ;
Hurding, Simon ;
Bennie, Marion ;
Morton, Alec .
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2018, 7 (04) :142-151
[10]   Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications [J].
Godman, Brian ;
Wettermark, Bjorn ;
van Woerkom, Menno ;
Fraeyman, Jessica ;
Alvarez-Madrazo, Samantha ;
Berg, Christian ;
Bishop, Iain ;
Bucsics, Anna ;
Campbell, Stephen ;
Finlayson, Alexander E. ;
Fuerst, Jurij ;
Garuoliene, Kristina ;
Herholz, Harald ;
Kalaba, Marija ;
Laius, Ott ;
Piessnegger, Jutta ;
Sermet, Catherine ;
Schwabe, Ulrich ;
Vlahovic-Palcevski, Vera V. ;
Markovic-Pekovic, Vanda ;
Voncina, Luka ;
Malinowska, Kamila ;
Zara, Corinne ;
Gustafsson, Lars L. .
FRONTIERS IN PHARMACOLOGY, 2014, 5